Hobart Private Capital, LLC Abbott Laboratories Transaction History

Hobart Private Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 11, 2024	SELL	$115.53 - $141.46 $643,617 - $788,073	-5,571 Closed	0 $0
Q3 2021 Mar 11, 2024	SELL	$116.66 - $129.06 $34,764 - $38,459	-298 Reduced 5.08%	5,571 $658 Million
Q2 2021 Mar 11, 2024	SELL	$105.79 - $124.53 $83,256 - $98,005	-787 Reduced 11.82%	5,869 $680 Million
Q1 2021 Mar 11, 2024	BUY	$108.84 - $128.23 $724,439 - $853,498	6,656 New	6,656 $798 Million
Q4 2020 Mar 11, 2024	BUY	$105.0 - $114.42 $40,740 - $44,394	388 Added 6.95%	5,972 $654 Million
Q3 2020 Mar 11, 2024	BUY	$91.64 - $111.29 $49,852 - $60,541	544 Added 10.79%	5,584 $608 Million
Q2 2020 Mar 11, 2024	BUY	$76.57 - $98.0 $187,366 - $239,806	2,447 Added 94.37%	5,040 $461 Million
Q1 2020 Mar 11, 2024	BUY	$62.82 - $91.86 $162,892 - $238,192	2,593 New	2,593 $205 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Hobart Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Hobart Private Capital, LLC with notifications on news.